van Miert, J. H. A., Veeger, N. J. G. M., & Meijer, K. (2019). An easy-to-use tool to flag patients at risk of poor INR control: A streak of subtherapeutic INRs. Thrombosis Research, 181, 46-51. https://doi.org/10.1016/j.thromres.2019.06.006

Croles, F. N., Lukens, M. V., Mulder, R., de Maat, M. P. M., Mulder, A. B., & Meijer, K. (2019). Monitoring of heparins in antithrombin-deficient patients. Thrombosis Research, 175, 8-12. https://doi.org/10.1016/j.thromres.2019.01.007

PALLADIO Study Investigators, Riva, N., Righini, M., Camporese, G., Iotti, M., Bucherini, E., ... Ageno, W. (2019). Accuracy of age-adjusted D-dimer to rule out deep vein thrombosis in the elderly. Thrombosis Research, 174, 148-150. https://doi.org/10.1016/j.thromres.2018.12.024

RIETE Investigators, Moustafa, F., Stehouwer, A., Kamphuisen, P., Carles Sahuquillo, J., Samperiz, A., ... Monreal, M. (2018). Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism. Thrombosis Research, 171, 74-80. https://doi.org/10.1016/j.thromres.2018.09.049

Lameijer, H., Aalberts, J. J. J., van Veldhuisen, D. J., Meijer, K., & Pieper, P. G. (2018). Efficacy and safety of direct oral anticoagulants during pregnancy; a systematic literature review. Thrombosis Research, 169, 123-127. https://doi.org/10.1016/j.thromres.2018.07.022

Croles, F. N., Mulder, R., Mulder, A. B., Lukens, M. V., & Meijer, K. (2018). beta-Antithrombin, subtype of antithrombin deficiency and the risk of venous thromboembolism in hereditary antithrombin deficiency: A family cohort study. Thrombosis Research, 168, 47-52. https://doi.org/10.1016/j.thromres.2018.06.004

Moesker, M. J., Damen, N. L., Volmeijer, E. E., Dreesens, D., de Loos, E. M., Vink, R., ... Wagner, C. (2018). Guidelines' risk assessment recommendations for venous thromboembolism prophylaxis: A comparison and implementability appraisal. Thrombosis Research, 168, 5-13. https://doi.org/10.1016/j.thromres.2018.05.028

van Pelt, L. J., Lukens, M. V., Testa, S., Chatelain, B., Douxfils, J., & Mullier, F. (2018). The DaXa-inhibition assay: A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugs. Thrombosis Research, 168, 63-66. https://doi.org/10.1016/j.thromres.2018.04.024

van Es, N., Hisada, Y., Di Nisio, M., Cesarman, G., Kleinjan, A., Mahe, I., ... Nieuwland, R. (2018). Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study. Thrombosis Research, 166, 54-59. https://doi.org/10.1016/j.thromres.2018.04.009

Wilts, I. T., Hutten, B. A., Meijers, J. C. M., Spek, C. A., Buller, H. R., & Kamphuisen, P. W. (2017). Association between protein C levels and mortality in patients with advanced prostate, lung and pancreatic cancer. Thrombosis Research, 154, 15-20. https://doi.org/10.1016/j.thromres.2017.03.001

Wilts, I. T., Le Gal, G., Den Exter, P. L., Van Es, J., Carrier, M., Planquette, B., ... Kamphuisen, P. W. (2017). Performance of the age-adjusted cut-off for D-dimer in patients with cancer and suspected pulmonary embolism. Thrombosis Research, 152, 49-51. https://doi.org/10.1016/j.thromres.2017.02.007

Lisman, T., & Bernal, W. (2017). Hemostatic issues in pregnancy-induced liver disease. Thrombosis Research, 151(Suppl. 1), S78-S81. https://doi.org/10.1016/S0049-3848(17)30073-7

Bos, S., Potze, W., Siddiqui, M. S., Boyett, S. L., Adelmeijer, J., Daita, K., ... Sanyal, A. J. (2017). Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease. Thrombosis Research, 150, 41-43. https://doi.org/10.1016/j.thromres.2016.12.008

van Es, N., Bleker, S. M., Di Nisio, M., Kleinjan, A., Beyer-Westendorf, J., Camporese, G., ... Bossuyt, P. M. (2016). A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients For the ARMOUR study investigators. Thrombosis Research, 148, 59-62. https://doi.org/10.1016/j.thromres.2016.10.019

Tichelaar, Y. I. G. V., & Lijfering, W. M. (2016). Who is at high risk of recurrent venous thrombosis and do they really benefit from continuation of anticoagulation? Clinicians wield a double-edged sword that might cut nothing at all. Thrombosis Research, 143, 150-+. https://doi.org/10.1016/j.thromres.2016.05.006

Isaksen, T., Tichelaar, Y. I. G. V., Skjeldestad, F. E., Brodin, E. E., Vik, A., Singh, K., & Hansen, J-B. (2016). Inter-rater agreement between professional-rated and patient-rated scores of the Villalta scale for evaluation of the post-thrombotic syndrome. Thrombosis Research, 141, 175-177. https://doi.org/10.1016/j.thromres.2016.03.027

Kleiss, S. F., Adelmeijer, J., Meijers, J. C. M., Porte, R. J., & Lisman, T. (2016). A sustained decrease in plasma fibrinolytic potential following partial liver resection or pancreas resection. Thrombosis Research, 140, 36-40. https://doi.org/10.1016/j.thromres.2016.02.011

Svilaas, T., Lefrandt, J., Gietema, J., & Kamphuisen, P. W. (2016). Long-term arterial complications of chemotherapy in patients with cancer. Thrombosis Research, 140 (Supplement 1), S109-S118. https://doi.org/10.1016/S0049-3848(16)30109-8

Sneeboer, M. M. S., Hutten, B. A., Majoor, C. J., Bel, E. H. D., & Kamphuisen, P. W. (2016). Oral and inhaled corticosteroid use and risk of recurrent pulmonary embolism. Thrombosis Research, 140, 46-50. https://doi.org/10.1016/j.thromres.2016.02.010

ten Cate-Hoek, A. J., Weitz, J. I., Gailani, D., Meijer, K., Philippou, H., Bouman, A. C., ... Buller, H. R. (2015). Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS). Thrombosis Research, 136, S13-S18. https://doi.org/10.1016/j.thromres.2015.07.036

van Es, J., Douma, R. A., Hezemans, R. E. L., Penaloza, A., Motte, S., Erkens, P. G. M., ... Kamphuisen, P. W. (2015). Accuracy of X-ray with perfusion scan in young patients with suspected pulmonary embolism. Thrombosis Research, 136(2), 221-224. https://doi.org/10.1016/j.thromres.2015.05.018

Tichelaar, V. (2015). Determinants and consequences of differences in quality of anticoagulation therapy with vitamin K antagonists. Thrombosis Research, 136(2), 183-184. https://doi.org/10.1016/j.thromres.2015.05.009

Potze, W., Adelmeijer, J., Porte, R. J., & Lisman, T. (2015). Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosis. Thrombosis Research, 135(5), 1012-1016. https://doi.org/10.1016/j.thromres.2015.02.025

Mulder, R., Croles, F. N., Lukens, M. V., Meijer, K., & Mulder, A. B. (2015). A novel c.290G > A mutation in the Factor 11 gene in a Dutch Caucasian family with a Factor XI deficiency. Thrombosis Research, 135(4), 767-769. https://doi.org/10.1016/j.thromres.2015.01.014

Alkozai, E. M., Porte, R. J., Adelmeijer, J., Zanetto, A., Simioni, P., Senzolo, M., & Lisman, T. (2015). No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma. Thrombosis Research, 135(2), 292-297. https://doi.org/10.1016/j.thromres.2014.11.016

Khorsand, N., Kooistra, H. A. M., van Hest, R. M., Veeger, N. J. G. M., & Meijer, K. (2015). A systematic review of prothrombin complex concentrate dosing strategies to reverse vitamin K antagonist therapy. Thrombosis Research, 135(1), 9-19. https://doi.org/10.1016/j.thromres.2014.11.019

Riva, N., Ageno, W., Schulman, S., Bang, S. M., Teresa Sartori, M., Grandone, E., ... Dentali, F. (2014). Vitamin K antagonists versus heparin for the treatment of splanchnic vein thrombosis in the ISTH registry: Results of 12-month follow-up and a propensity score analysis. Thrombosis Research, 134, 34-35.

Lisman, T. (2014). Low molecular weight heparin in management and prevention of portal vein thrombosis. Thrombosis Research, 134(4), 761-762. https://doi.org/10.1016/j.thromres.2014.08.003

Groeneveld, D., Porte, R. J., & Lisman, T. (2014). Thrombomodulin-modified thrombin generation testing detects a hypercoagulable state in patients with cirrhosis regardless of the exact experimental conditions. Thrombosis Research, 134(3), 753-756. https://doi.org/10.1016/j.thromres.2014.07.010

Mos, I. C. M., Douma, R. A., Erkens, P. M. G., Kruip, M. J. H. A., Hovens, M. M., van Houten, A. A., ... Prometheus Study Grp (2014). Diagnostic outcome management study in patients with clinically suspected recurrent acute pulmonary embolism with a structured algorithm. Thrombosis Research, 133(6), 1039-1044. https://doi.org/10.1016/j.thromres.2014.03.050

Kamphuisen, P. W., & Beyer-Westendorf, J. (2014). Bleeding complications during anticoagulant treatment in patients with cancer. Thrombosis Research, 133(SUPPL. 2), S49-S55. https://doi.org/10.1016/S0049-3848(14)50009-6

Van Der Hulle, T., Den Exter, P., Mos, I., Kamphuisen, P., Hovens, M., Kruip, M., ... Klok, E. (2014). C0197: Optimization of the diagnostic management of clinically suspected pulmonary embolism in hospitalized patients. Thrombosis Research, 133, 32. https://doi.org/10.1016/S0049-3848(14)50118-1

van Es, N., Bleker, S. M., Di Nisio, M., Kamphuisen, P. W., Otten, H. M., Mahe, I., ... Buller, H. R. (2014). External validation of current VTE risk prediction scores for patients with solid cancer in an ongoing prospective multicenter cohort study. Thrombosis Research, 133, S208-S209.

Willemze, R., Bradford, R. L., Mooberry, M. J., Roubey, R. A. S., & Key, N. S. (2014). Plasma Microparticle Tissue Factor Activity in Patients With Antiphospholipid Antibodies With and Without Clinical Complications. Thrombosis Research, 133(2), 187-189. https://doi.org/10.1016/j.thromres.2013.11.027

van Es, J., den Exter, P. L., Kaptein, A. A., Andela, C. D., Erkens, P. M. G., Klok, F. A., ... Middeldorp, S. (2013). Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL. Thrombosis Research, 132(5), 500-505. https://doi.org/10.1016/j.thromres.2013.06.016

Krzek, M., Ciesla-Dul, M., Zabczyk, M., & Undas, A. (2012). Fibrin clot properties in women heterozygous for factor V Leiden mutation: effects of oral contraceptives. Thrombosis Research, 130(4), 216-221. [10.1016/j.thromres.2012.08.302]. https://doi.org/10.1016/j.thromres.2012.08.302

Knol, H. M., Schultinge, L., Veeger, N. J. G. M., Kluin-Nelemans, H. C., Erwich, J. J. H. M., & Meijer, K. (2012). The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy. Thrombosis Research, 130(3), 334-338. https://doi.org/10.1016/j.thromres.2012.03.007

Huet, R. C. G. G., Cernak, V., de Vries, A. J., & Lisman, T. (2012). Bivalirudin is inferior to heparin in preservation of intraoperative autologous blood. Thrombosis Research, 130(2), 163-165. https://doi.org/10.1016/j.thromres.2011.12.024

Kleinjan, A., Aggerwal, A., Van Der Geer, A., Kamphuisen, P. W., Rickles, F. R., Faselis, C., & Büller, H. R. (2012). A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism. Thrombosis Research, 129, 183. https://doi.org/10.1016/S0049-3848(12)70109-3

Kleinjan, A., Berckmans, R. J., Böing, A. N., Sturk, A., Büller, H. R., Kamphuisen, P. W., & Nieuwland, R. (2012). Cellular origin and procoagulant activity of tissue factor-exposing microparticles in cancer patients. Thrombosis Research, 129, 161. https://doi.org/10.1016/S0049-3848(12)70049-X

Tichelaar, V., Mulder, A., Kluin-Nelemans, H., & Meijer, K. (2012). The acute phase reaction explains only a part of initially elevated factor VIII: C levels: A prospective cohort study in patients with venous thrombosis. Thrombosis Research, 129(2), 183-186. https://doi.org/10.1016/j.thromres.2011.09.024

Mahmoodi, B. K., Nijsten, M., Wijsman, J., Matthews, A. G., & van der Laan, L. (2012). ABO-blood groups and risk of abdominal aortic aneurysm and peripheral obstructive artery disease: Two sides of the same coin. Thrombosis Research, 129(1), 89-90. https://doi.org/10.1016/j.thromres.2011.09.028

Mulder, R., Tichelaar, V. Y. I. G., Lijfering, W. M., Kluin-Nelemans, H. C., Mulder, A. B., & Meijer, K. (2011). Decreased free protein S levels and venous thrombosis in the acute setting, a case-control study. Thrombosis Research, 128(5), 501-502. https://doi.org/10.1016/j.thromres.2011.06.015

Resh, M., Mahmoodi, B. K., Navis, G. J., Veeger, N. J. G. M., & Lijfering, W. M. (2011). Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism. Thrombosis Research, 127(5), 395-399. https://doi.org/10.1016/j.thromres.2010.12.020

de Groot, P. G. (2011). Mechanisms of anti-phospholipid antibody formation and action. Thrombosis Research, 127, S40-S42.

Mulder, R., van Schouwenburg, I. M., Mahmoodi, B. K., Veeger, N. J. G. M., Mulder, A. B., Middeldorp, S., ... Lijfering, W. M. (2010). Associations between high factor VIII and low free protein S levels with traditional arterial thrombotic risk factors and their risk on arterial thrombosis: Results from a retrospective family cohort study. Thrombosis Research, 126(4), E249-E254. https://doi.org/10.1016/j.thromres.2010.07.013

Douma, R. A., Kok, M. G. M., Verberne, L. M., Kamphuisen, P. W., & Büller, H. R. (2010). Incidental venous thromboembolism in cancer patients: prevalence and consequence. Thrombosis Research, 125(6), e306-e309. https://doi.org/10.1016/j.thromres.2010.02.010

Borensztajn, K., Peppelenbosch, M. P., & Spek, C. A. (2010). Coagulation Factor Xa inhibits cancer cell migration via LIMK1-mediated cofilin inactivation. Thrombosis Research, 125(6), E323-E328. https://doi.org/10.1016/j.thromres.2010.02.018

Nossent, A. Y., Ellenbroek, J. H., Frölich, M., Bertina, R. M., Knoers, N. V. A. M., & Eikenboom, J. C. J. (2010). Plasma levels of von Willebrand factor, von Willebrand factor propeptide and factor VIII in carriers and patients with nephrogenic diabetes insipidus. Thrombosis Research, 125(6), 554-6. https://doi.org/10.1016/j.thromres.2010.03.014

Kleinjan, A., Di Nisio, M., Kamphuisen, P. W., & Büller, H. R. (2010). Safety and feasibility of a diagnostic algorithm combining clinical probability, D-dimer test and ultrasonography in suspected upper extremity deep vein thrombosis. Thrombosis Research, 125, 169. https://doi.org/10.1016/S0049-3848(10)70062-1